StockData
ClearPoint Neuro, Inc. logo

ClearPoint Neuro, Inc. (CLPT) income statement

CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3012% above fair value
$7.71−0.15 (-1.91%)

Close on Nov 18, 2026Market cap $247.14MP/E –Yield –

ClearPoint Neuro, Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
61.4%
Operating margin
-70.6%
Net margin
-79.4%
Return on equity, FY2025
-95.6%

Financial strength

Current ratio
6.76
Debt to equity
1.86
Debt to assets
45.1%
Cash to current liabilities
468.0%

Valuation

P/E ratio
–
Price to sales
5.43
Price to book
9.06
Dividend yield
–

See a number that looks wrong?